NYSEAMERICAN:OCX - OncoCyte Corporation
$2.06
 $0.00
0.00%
12:15PM EDT
2019-07-22
OncoCyte Corporation (OncoCyte), incorporated on September 30, 2009, is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. It operates through the research and development of diagnostic tests for the detection of cancer segment. Its initial focus will be confirmatory diagnostics, utilizing liquid biopsy technology, for use in conjunction with imaging to confirm initial diagnoses within certain oncology indications. In addition, it will be developing screening diagnostics as replacements for screening imaging procedures. For some indications, it will also be pursuing the probability of recurrence of a specific cancer through the development of prognostics or companion diagnostics that help a physician determine which therapy is the optimal treatment for the patient.The Company's diagnostic tests (lung, breast and bladder cancer tests) are in the assay development-stage. The Company is collaborating with The Wistar Institute of Anatomy and Biology (Wistar) to develop the confirmatory lung cancer diagnostic test in a multi-site clinical study evaluating the blood-based lung cancer diagnostic test. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  OCX     avg for
industry  
  avg for
sector  
42 stocks weight:  8. 13   217. 37   399. 45  
42 stocks rank:  3. 93 K 1. 27 K 716. 99  
# analyst opinions:  5. 00   13. 21   13. 71  
mean recommendation:  1. 80   2. 10   2. 04  

quick ratio:  12. 47   5. 49   1. 88  
current ratio:  12. 82   5. 87   2. 36  

target price low:  2. 28   83. 44   114. 90  
target price avg:  2. 55   106. 20   137. 90  
target price high:  6. 00   132. 30   158. 97  
1-yr high:  5. 91   111. 86   142. 57  
last close:  2. 06   86. 79   125. 44  
50-day avg:  3. 52   86. 68   122. 63  
200-day avg:  3. 00   89. 22   121. 38  
1-yr low:  1. 38   69. 78   100. 51  
volume:  137. 62 K 2. 62 M 3. 43 M
50-day avg volume:  407. 53 K 3. 20 M 4. 16 M
200-day avg volume:  547. 07 K 2. 99 M 4. 75 M

1-day return:  -0. 48 % -1. 30 % -0. 99 %
this week return:  0. 98 % 0. 45 % -0. 20 %
12-wk return:  -52. 42 % 0. 94 % 4. 84 %
52-wk return:  -33. 75 % -1. 30 % 10. 55 %

enterprise value (EV):  71. 72 M 45. 10 B 122. 38 B
market cap:  107. 07 M 38. 96 B 108. 40 B
EBITDA:  -14. 16 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -5. 06   5. 38   11. 93  
total debt:  1. 40 M 10. 90 B 17. 48 B
debt/equity:  3. 66   57. 18   120. 05  
net income (common):  -15. 84 M 2. 07 B 4. 05 B

shares outstanding:  0. 00   538. 09 M 1. 24 B
shares:  20. 27 M 548. 00 M 1. 22 B
shares short:  943. 15 K 10. 98 M 11. 87 M
shares short prior month:  583. 03 K 9. 32 M 12. 05 M
short ratio:  2. 06   5. 60   3. 34  
short % of float:  3. 29 % 6. 48 % 2. 64 %
total cash/share:  0. 77   10. 98   9. 19  
total cash:  39. 86 M 5. 93 B 6. 10 B
free cash flow:  -9. 76 M 2. 92 B 4. 55 B
operating cash flow:  -15. 61 M 3. 80 B 5. 78 B

book value:  0. 73   13. 35   27. 45  
price/book:  2. 80   4. 60   8. 78  
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  224. 87 % --- ---
1-yr mean volatility:  5. 07 % 1. 66 % 1. 03 %

1-yr EPS:  -0. 38   2. 10   4. 23  
forward EPS:  -0. 39   3. 45   7. 10  
P/E:  -5. 41   1. 90   32. 10  
forward P/E:  -5. 31   6. 46   15. 47  
PE/G:  0. 80   0. 70   -0. 54  
growth:  -6. 73 % 265. 63 % 79. 11 %
earnings high:  -0. 08   0. 89   1. 68  
earnings avg:  -0. 09   0. 70   1. 57  
earnings low:  -0. 10   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -32. 02 % -2. 34 % 5. 28 %
return on equity:  -67. 11 % -90. 08 % 133. 53 %

beta (1yr vs S&P500):  0. 78   1. 27   0. 91  
sharpe (1yr):  0. 46   0. 16   0. 77  

held % insiders:  47. 30 % 6. 06 % 3. 29 %
held % institutions:  21. 97 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : OCX
.    101.259 =       101.259 :: --> INITIAL WEIGHT <--
.    - 0.381 =       100.878 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.     x 2.13 =       214.861 :: P/E factor
.    x 1.056 =       226.918 :: PE/G factor
.    x 1.703 =       386.347 :: beta factor
.    x 0.802 =       309.875 :: sharpe factor
.    x 2.185 =       677.102 :: current ratio factor
.    x 1.043 =       706.004 :: quick ratio factor
.    x 1.219 =       860.467 :: short ratio factor
.    x 1.026 =       882.868 :: price-to-book factor
.    x 1.031 =        910.67 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      1931.342 :: sector+industry 1-year gains factor
.    x 1.009 =       1949.55 :: industry 12-weeks return factor
.    x 1.308 =      2549.795 :: industry 2-weeks return factor
.    x 1.176 =      2997.645 :: 50-day avg > 200-day avg
.    x 0.998 =      2991.983 :: "drift" penalty 1 days ago
.    / 2.281 =      1311.926 :: overall "drift" factor
.    x 0.347 =       454.865 :: largest single-day jump factor
.    x 0.066 =        30.084 :: low price factor
.    x 1.025 =        30.823 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.152 =         4.688 :: forward EPS factor
.    x 0.692 =         3.244 :: forward P/E factor
.    x 1.185 =         3.843 :: industry recommendation factor
.    x 2.389 =          9.18 :: company recommendation factor
.    x 1.003 =         9.206 :: factor historical industry gain for week 29
.    x 1.402 =        12.903 :: target low factor
.    x 1.162 =        14.994 :: target mean factor
.    x 1.058 =        15.865 :: target high factor
.    x 10.77 =       170.856 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         3.615 :: reduced for readability
.    + 4.516 =         8.131 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      8.131 :: FINAL WEIGHT for NYSEAMERICAN:OCX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org